CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | -9.4% | 968 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $32 | -11.1% | 968 | -4.9% | 0.00% | -50.0% |
| Q1 2023 | $36 | -23.4% | 1,018 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $47 | -99.9% | 1,018 | -11.1% | 0.00% | -33.3% |
| Q3 2022 | $55,000 | +41.0% | 1,145 | +14.8% | 0.00% | +50.0% |
| Q2 2022 | $39,000 | -27.8% | 997 | -31.9% | 0.00% | 0.0% |
| Q1 2022 | $54,000 | -19.4% | 1,464 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $67,000 | – | 1,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |